On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...